Cargando…
Expression of androgen receptor and its regulatory molecule Lin28 in non-luminal subtype breast cancer
Androgen receptor (AR) was associated with favourable outcome in luminal breast cancer. However, the role of AR in non-luminal breast cancer remains inconclusive. The aim of the present study was to evaluate the clinical significance of the AR and its regulatory pathway in non-luminal subtypes of br...
Autores principales: | Sa-Nguanraksa, Doonyapat, Pongthong, Wanee, Samarnthai, Norasate, Mitpakdi, Kwanlada, Chuangsuwanich, Tuenjai, Limjindaporn, Thawornchai, Kulprom, Anchalee, O-Charoenrat, Pornchai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201307/ https://www.ncbi.nlm.nih.gov/pubmed/32382417 http://dx.doi.org/10.3892/mco.2020.2029 |
Ejemplares similares
-
Gail Model Underestimates Breast Cancer Risk in Thai Population
por: Sa-Nguanraksa, Doonyapat, et al.
Publicado: (2019) -
The role of Prolactin/Prolactin Receptor polymorphisms and expression in breast cancer susceptibility and outcome
por: Sa-nguanraksa, Doonyapat, et al.
Publicado: (2020) -
Filariasis of the breast caused by Brugia pahangi: A concomitant finding with invasive ductal carcinoma
por: Thongpiya, Jerapas, et al.
Publicado: (2021) -
The Role of Vascular Endothelial Growth Factor A Polymorphisms in Breast Cancer
por: Sa-nguanraksa, Doonyapat, et al.
Publicado: (2012) -
The Evaluation of Magee Equation 2 in Predicting Response and Outcome in Hormone Receptor-Positive and HER2-Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Saigosoom, Napat, et al.
Publicado: (2020)